Eargo, which makes tech-enabled hearing aids, announced Tuesday that healthcare investment firm Patient Square Capital is the new majority owner of the company.
Patient Square now holds approximately 76.3% of Eargo stock through the conversion of senior secured convertible notes it had purchased this summer and following a recent rights offering of common stock.
Eargo said the offering brought in...
Hearing technology and audiology care company Yes Hearing, which provides an online platform and at-home treatment for the hearing impaired, scored $10 million in Series A funding round led by Blue Heron Capital.
Other participants in the round include Ensemble Innovation Ventures, Primetime Partners, Maccabee Ventures and Gaingels.
WHAT IT'S FOR
The new investment round will help the company...
Smart-hearing company Eargo rolled out its sixth-generation hearing aid. The technology comes with a sound-adjust algorithm designed to change volume based on surrounding noise without the user manually adjusting the device.
Eargo also added a new feature called “mask mode,” created to help mitigate the challenges individuals with hearing loss face when speaking to someone wearing a mask. The...
Smart hearing company Eargo is the target of a criminal investigation by the U.S. Department of Justice (DOJ), the company said in a Securities and Exchange Commission (SEC) filing Wednesday.
The DOJ is looking into Eargo’s insurance reimbursement claims that it submits on behalf of its customers when they purchase the company’s connected hearing aids.
The probe is part of an “ongoing claims...
Smart hearing company Eargo has released its latest connected hearing aids, the Eargo 5, equipped with smaller specs and new features.
Chief to Eargo’s smart hearing devices is the ability for users to customize their sound settings depending on their preferences and environment. The company created a new in-app screening test for users to establish a personalized hearing profile based on the...
Eargo hit the public market today with an initial public offering of about 7.9 million shares of common stock priced at $18 per share for estimated earnings of about $141.3 million.
This IPO is upsized from its original offering of about 6.7 million common stock shares priced between $14 and $16. Eargo has also granted the underwriters the option to purchase an additional 1.2 million shares at...
Eargo, maker of direct-to-consumer tech enabled hearing devices, scored a whopping $71 million in Series funding. Gilde Healthcare and Longitude Capital led the round with participation from New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences.
As part of the news, the company announced that Gilde Healthcare’s Geoff Pardo and Longitude Capital’s Juliet...
The expectations and lifestyles of baby boomers are quickly shaping the way new technologies are developing, and this includes hearing aids and related devices.
“They are the largest consumer of healthcare services, and they are very avid consumers of healthcare information and seek out information themselves,” Daniel Shen, founder of hearing aid company Eargo, said at the Connected Health...
